NCT01427439 A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder Status COMPLETED Phase N/A
NCT01426516 Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1) Status TERMINATED Phase NA
NCT01422213 Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01421342 VA Augmentation and Switching Treatments for Improving Depression Outcomes Status COMPLETED Phase PHASE3
NCT01418638 The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder Status UNKNOWN Phase N/A
NCT01415154 Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder Status COMPLETED Phase NA
NCT01409317 Neural Predictors and Longitudinal Neural Correlates of Deep Transcranial Magnetic Stimulation for Treating Major Depression Status COMPLETED Phase PHASE2/PHASE3
NCT01409304 Effectiveness of Deep Transcranial Magnetic Stimulation in Depression Status COMPLETED Phase PHASE2/PHASE3
NCT01397903 Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response Status COMPLETED Phase N/A
NCT01395147 Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01385709 The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels Status COMPLETED Phase N/A
NCT01381107 ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD Status COMPLETED Phase PHASE1/PHASE2
NCT01380704 Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder Status COMPLETED Phase PHASE1